Corporate Outline

tella, Inc.

Company name tella, Inc.
Address 1F Mitsuihanagiri Bldg, 7-22-36 Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023
TEL: +81-3-5937-2111
FAX: +81-3-5937-2112
Capital Amount JPY 2,722 million yen(as of December 2019)
Directors and Corporate Auditors President, Representative director : Tomoyuki Taira
Director of the Board : Sei-ichi Yusa
Outside Director, Audit & Supervisory Committee : Norihiko Akashi
Outside Director, Audit & Supervisory Committee : Katsuiku Hirokawa
Outside Director, Audit & Supervisory Committee : Tetsuya Fujimori
Principal Business Activities
  • ・Provision of techniques and operational knowhow associated with cell medicines, including dendritic cell vaccine therapy, to affiliated medical institutions.
  • ・Research and Development of regenerative medicine and cell medicine,including dendritic cell vaccine therapy.
Subsidiaries Tella Pharma, Inc.

Tella Pharma, Inc.

Company name Tella Pharma, Inc.
Address Head office
20F, Shinjuku i-Land Tower, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1320, Japan

1F, Mitsuihanagiri Bldg, 7-22-36 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan

TONOMACHI Cell Processing Center
#204 Life Innovation Center 204, 3-25-22 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa 210-0821, Japan
Principal Business Activities
  • Research, and planning related to research, development/testing, manufacturing, contract manufacturing, trading, import/export of pharmaceutical products, medical devices, regenerative medicine products, and their investigation and planning, etc.
Subsidiaries Tella Pharma, Inc.